246 related articles for article (PubMed ID: 32085797)
1. Inhibition of growth of Asian keloid cells with human umbilical cord Wharton's jelly stem cell-conditioned medium.
Arjunan S; Gan SU; Choolani M; Raj V; Lim J; Biswas A; Bongso A; Fong CY
Stem Cell Res Ther; 2020 Feb; 11(1):78. PubMed ID: 32085797
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro.
Gauthaman K; Yee FC; Cheyyatraivendran S; Biswas A; Choolani M; Bongso A
J Cell Biochem; 2012 Jun; 113(6):2027-39. PubMed ID: 22275115
[TBL] [Abstract][Full Text] [Related]
3. Human keloid cell characterization and inhibition of growth with human Wharton's jelly stem cell extracts.
Fong CY; Biswas A; Subramanian A; Srinivasan A; Choolani M; Bongso A
J Cell Biochem; 2014 May; 115(5):826-38. PubMed ID: 24265231
[TBL] [Abstract][Full Text] [Related]
4. Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds.
Fong CY; Tam K; Cheyyatraivendran S; Gan SU; Gauthaman K; Armugam A; Jeyaseelan K; Choolani M; Biswas A; Bongso A
J Cell Biochem; 2014 Feb; 115(2):290-302. PubMed ID: 24038311
[TBL] [Abstract][Full Text] [Related]
5. Human Wharton's jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice.
Gauthaman K; Fong CY; Arularasu S; Subramanian A; Biswas A; Choolani M; Bongso A
J Cell Biochem; 2013 Feb; 114(2):366-77. PubMed ID: 22930595
[TBL] [Abstract][Full Text] [Related]
6. Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium.
Lin DH; Biswas A; Choolani M; Fong CY; Bongso A
Stem Cell Rev Rep; 2017 Dec; 13(6):801-816. PubMed ID: 28918474
[TBL] [Abstract][Full Text] [Related]
7. Human Wharton's Jelly Stem Cell Secretions Inhibit Human Leukemic Cell Line K562
Huwaikem MAH; Kalamegam G; Alrefaei G; Ahmed F; Kadam R; Qadah T; Sait KHW; Pushparaj PN
Front Cell Dev Biol; 2021; 9():614988. PubMed ID: 33869169
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.
Fong CY; Gauthaman K; Cheyyatraivendran S; Lin HD; Biswas A; Bongso A
J Cell Biochem; 2012 Feb; 113(2):658-68. PubMed ID: 21976004
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic human umbilical cord Wharton's jelly stem cells increase several-fold the expansion of human cord blood CD34+ cells both in vitro and in vivo.
Lin HD; Fong CY; Biswas A; Bongso A
Stem Cell Res Ther; 2020 Dec; 11(1):527. PubMed ID: 33298170
[TBL] [Abstract][Full Text] [Related]
10. Human Umbilical Cord Wharton's Jelly Stem Cell Conditioned Medium Induces Tumoricidal Effects on Lymphoma Cells Through Hydrogen Peroxide Mediation.
Lin HD; Fong CY; Biswas A; Choolani M; Bongso A
J Cell Biochem; 2016 Sep; 117(9):2045-55. PubMed ID: 27392313
[TBL] [Abstract][Full Text] [Related]
11. Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts.
Arno AI; Amini-Nik S; Blit PH; Al-Shehab M; Belo C; Herer E; Jeschke MG
Stem Cells Transl Med; 2014 Mar; 3(3):299-307. PubMed ID: 24436441
[TBL] [Abstract][Full Text] [Related]
12. Human Wharton's jelly stem cells inhibit endometriosis through apoptosis induction.
Hajazimian S; Maleki M; Mehrabad SD; Isazadeh A
Reproduction; 2020 May; 159(5):549-558. PubMed ID: 32155128
[TBL] [Abstract][Full Text] [Related]
13. A nanoscaffold impregnated with human wharton's jelly stem cells or its secretions improves healing of wounds.
Tam K; Cheyyatraviendran S; Venugopal J; Biswas A; Choolani M; Ramakrishna S; Bongso A; Fong CY
J Cell Biochem; 2014 Apr; 115(4):794-803. PubMed ID: 24265214
[TBL] [Abstract][Full Text] [Related]
14. Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells.
Lin HD; Fong CY; Biswas A; Choolani M; Bongso A
Stem Cell Rev Rep; 2014 Aug; 10(4):573-86. PubMed ID: 24789672
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic Wharton's Jelly Stem Cell Conditioned Medium Induces Immunogenic Cell Death in Lymphoma Cells.
Lin HD; Fong CY; Biswas A; Bongso A
Stem Cells Int; 2020; 2020():4670948. PubMed ID: 32377203
[TBL] [Abstract][Full Text] [Related]
16. Human Wharton's Jelly Stem Cell (hWJSC) Extracts Inhibit Ovarian Cancer Cell Lines OVCAR3 and SKOV3
Kalamegam G; Sait KHW; Ahmed F; Kadam R; Pushparaj PN; Anfinan N; Rasool M; Jamal MS; Abu-Elmagd M; Al-Qahtani M
Front Oncol; 2018; 8():592. PubMed ID: 30581772
[TBL] [Abstract][Full Text] [Related]
17. Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.
Fong CY; Subramanian A; Biswas A; Bongso A
J Cell Biochem; 2016 Apr; 117(4):815-27. PubMed ID: 26365815
[TBL] [Abstract][Full Text] [Related]
18. Manufacturing of human Wharton's jelly stem cells for clinical use: selection of serum is important.
Kong CM; Lin HD; Biswas A; Bongso A; Fong CY
Cytotherapy; 2019 Apr; 21(4):483-495. PubMed ID: 30879965
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells.
Subramanian A; Shu-Uin G; Kae-Siang N; Gauthaman K; Biswas A; Choolani M; Bongso A; Chui-Yee F
J Cell Biochem; 2012 Jun; 113(6):1886-95. PubMed ID: 22234854
[TBL] [Abstract][Full Text] [Related]
20. Expanded Differentiation Capability of Human Wharton's Jelly Stem Cells Toward Pluripotency: A Systematic Review.
Garzon I; Chato-Astrain J; Campos F; Fernandez-Valades R; Sanchez-Montesinos I; Campos A; Alaminos M; D'Souza RN; Martin-Piedra MA
Tissue Eng Part B Rev; 2020 Aug; 26(4):301-312. PubMed ID: 32085697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
